Tezepelumab for Severe Asthma Improves the Odds of a Good Night’s Sleep
However, analysis did not control for treatments of comorbid sleep disorders, expert points out
Related Articles
CBS Mornings on Instagram: “Seasonal allergies are getting worse for many Americans — and there is a likely culprit: Climate change. Dr. Lewis Ziska, an environmental health sciences associate professor, and Dr. @panipurvinyc, an immunologist and allergist, share why rising global temperatures are c
41 likes, 5 comments – cbsmornings on March 7, 2025: “Seasonal allergies are getting worse for many Americans — and there is a likely culprit:…
CDC Plans Large Study on Autism and Vaccines, Report Says
HHS Secretary Kennedy’s role in this research is unclear
Hotels – IMMUNOLOGY2025™
For IMMUNOLOGY2025™, we are offering convenient hotel options with flexible change and cancellation policies. Book early for the best selection and price!
Tack System Recall; Gene Hackman’s Pacemaker; Altitude and Valve Disease?
Recent developments of interest in cardiovascular medicine
«Es falso que la alergia no pueda aparecer en adultos; la enfermedad no tiene edad» | Ideal
La alergóloga Mari Ángeles Lara explica que padecerla puede ser consecuencia de que los «hijos pueden heredar la predisposición genética de los padres»
CDC Plans Large Study on Autism and Vaccines, Report Says
HHS Secretary Kennedy’s role in this research is unclear
Contents | Science Immunology 10, 105
ONLINE COVER Shining a Light on Mitochondrial Damage. Elevated type I interferon (IFN) in the epidermis of individuals with the autoimmune disorder cutaneous lupus erythromatosus…
The Path Forward for Long COVID Research – AAI News
Drs. Akiko Iwasaki and E. John Wherry share what research is telling us about the root causes of Long COVID and the path forward for…
Call for Section Editors
The Journal of Immunology (The JI), a prestigious fully peer-reviewed journal published by The American Association of Immunologists (AAI), seeks experienced im
FDA approves epinephrine nasal spray for children aged as young as 4 years
The FDA has approved neffy 1 mg epinephrine nasal spray for treating anaphylaxis and other type 1 allergic reactions in children aged 4 years and…